2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro
about
Regulation of hepatic innate immunity by hepatitis C virusOASL-a new player in controlling antiviral innate immunityCell-Based Screen Identifies Human Interferon-Stimulated Regulators of Listeria monocytogenes InfectionHepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cellsAvian influenza rapidly induces antiviral genes in duck lung and intestine.Cloning, expression and functional analysis of the duck Toll-like receptor 5 (TLR5) geneHepatitis C virus and antiviral innate immunity: who wins at tug-of-war?Interferon-stimulated genes and their antiviral effector functionsQuantitative Proteomics Reveals the Roles of Peroxisome-associated Proteins in Antiviral Innate Immune Responses.Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infectionIdentification of avian RIG-I responsive genes during influenza infectionVirus-host mucosal interactions during early SIV rectal transmission.Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1Identification of 2'-5'-Oligoadenylate Synthetase-Like Gene in Goose: Gene Structure, Expression Patterns, and Antiviral Activity Against Newcastle Disease Virus.Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection.Transcriptional profiling of the host cell response to feline immunodeficiency virus infection.CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.Immune Evasion Strategies during Chronic Hepatitis B and C Virus InfectionMolecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipientsContradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.Conserved Active-Site Residues Associated with OAS Enzyme Activity and Ubiquitin-Like Domains Are Not Required for the Antiviral Activity of goOASL Protein against Avian Tembusu Virus
P2860
Q26824743-66527FFA-ECF4-4862-AA19-DA6E8CC288A3Q28084356-F8DB1B34-D006-4223-B6E2-6E4610DAF5EAQ28555172-DA863D08-33B3-461A-90A3-71E6FFBD8B7EQ33664480-AFB17FB9-EC2B-4A2A-9761-29D743235B90Q34245896-DFA7CD64-F71B-410C-995D-BD97BCDE6286Q35199086-92FCE06D-1DF1-4CAF-A076-1A49D669A5CEQ35270150-B4D46FA2-3FC4-4D05-AA1F-0D2C69442F46Q35742006-8EDCD36B-466C-4A6E-830E-485F05EF48A9Q36040422-A76EC5EC-D532-42E5-919E-B9350076F228Q36112218-86C85B82-092A-4588-881B-D113EA39E87AQ36460968-C2ADC243-A047-4572-BD11-305571C8C3E2Q36590447-A157C203-D613-4154-8E76-FE488F75D5FEQ36731231-CD816AF6-DEBC-410E-8687-CF6758A8F8E1Q37286320-688CB561-0CA2-44E9-B617-D982BBD59E06Q38826361-C603D3CC-DA0D-4071-BBA7-02140B069565Q38958155-3C084241-5D08-4A65-BAA4-844BF9175E03Q38970471-92C64BFA-76EC-49B8-8628-44C9C6FDC6F7Q38981259-FE62DD04-47DF-4A64-8B43-6B9AC32FF479Q39327457-3C08B4C5-3312-4E2A-8250-CAFFFF353865Q42847746-3519B503-E349-4BB0-BCC3-69304CD8217CQ47564662-EE91991D-C75F-4F5B-A010-6B6BD16C804FQ50554860-0B0D683A-2035-419C-8B94-6DDFFB9B3EBFQ56397875-EC8C09A2-E43C-4EA1-8FA0-360A85C38FDB
P2860
2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@ast
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@en
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@en-gb
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@nl
type
label
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@ast
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@en
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@en-gb
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@nl
prefLabel
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@ast
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@en
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@en-gb
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@nl
P921
P3181
P1476
2',5'-Oligoadenylate synthetas ...... to viral replication in vitro
@en
P2093
Mariko Esumi
Mariko Ishibashi
P304
P3181
P356
10.1016/J.BBRC.2010.01.034
P407
P577
2010-02-12T00:00:00Z